Back to results
US 2014/0193843 A1Published application
Use of basic prolin-rich lacrimal gene products, such as opiorphin, as a biomarker
AssigneeInstitut Pasteur
InventorsCatherine ROUGEOT, Evelyne Dufour, Sylvie Villard-Saussine, Marie-Noelle Ungeheuer, Pierre Jouannet
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of Basic Prolin-rich Lacrimal protein (BPLP) gene products, such as Opiorphin, for establishing a prognosis, a diagnosis or the monitoring of a pathological state or of treatment efficacy in a subject and the related method of use.
Claims15
(canceled)
A method comprising quantitatively measuring a maturation product of a human BPLP protein in a biological sample obtained from a subject, wherein the biological sample is semen or tears.
Dependencies are inferred from the claim text.